4. risk increase with a hereditary mutation
TRANSCRIPT
PREVENTEST™A good physician treats the disease;
A great physician helps the pa3ent to prevent it
What is the PREVENTEST?The PREVENTEST, developed by GeneID Advanced Molecular Diagnos3cs, is the first Comprehensive Cancer Risk Assessment test designed to determine your risk of developing up to 8 cancer types. This non-‐invasive test helps the pa3ent and clinician determine the level of risk for some of the most common solid tumor cancers including Breast, Ovarian, Endometrial, Pancrea3c, Prostate, Skin, Gastric and Colorectal Cancers.
Hereditary Cancer
Annual Cases in General Popula6on1
Life6me Risk in General Popula6on1
Increased Risk Due to Gene6c Muta6on
(as high as)
Breast ~232,000 12.3% (females) 87%2
Ovarian ~22,000 1.4% 44%2
Endometrial (Uterine) ~50,000 2.7% 71%3
Colorectal ~143,000 4.8% >99%4
Gastric (Stomach) ~22,000 0.9% 80%5
Prostate ~239,000 15.3% (males) 44%6
Pancrea3c ~45,000 1.5% 36%7
Melanoma (Skin) ~143,000 4.8% 76%8
REFERENCES:1. Surveillance, Epidemiology and End Results Program, Na3onal Cancer Ins3tute (seer.cancer.gov) Dec 10, 2013.2. Ford D, et al. Risks of cancer in BRCA1-‐muta3on carriers. Breast Cancer Linkage Consor3um. Lancet. 1994 343:692-‐5. PMID: 79076783. Hendriks YM, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 muta3ons: impact on counseling and surveillance.
Gastroenterology. 2004 127:17-‐25. PMID: 15236168.4. Burt RW et al. NCCN Clinical Prac3ce Guidelines in Oncology® Colorectal Cancer Screening. V 2.20135. Kaurah P, Huntsman DG. Hereditary Diffuse Gastric Cancer. In: Pagon RA, et al., editors. GeneReviews. 20116. Cybulski C, et al. A large germline dele3on in the CHEK2 kinase gene is associated with an increased risk of prostate cancer. J Med Genet.
2006b :863-‐6. PMID: 170856827. van Lier MG, et al. High cancer risk in Peutz-‐Jeghers syndrome: a systema3c review and surveillance recommenda3ons. Am J Gastroenterol.
2010 105:1258-‐64. PMID: 200519418. Bishop DT, et al. Geographical varia3on in the penetrance of CDKN2A muta3ons for melanoma. J Natl Cancer Inst. 2002 94:894-‐903. PMID:
12072543
Please visit our website at www.PrevenTests.com